Clinical Trial: A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07087795) titled 'A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes' on June 29.

Brief Summary: This study is testing the effect of a new study medicine NNC0194-0499 in type 1 diabetes. The purpose of the study is to compare the effect of NNC0194-0499 on the blood sugar levels of participants with type 1 diabetes when taken in combination with semaglutide or placebo. All participants will receive standard of care insulin treatment. The study will last for about 36 weeks.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Diabetes Mellitus, T...